Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

5 Value Stocks In The Healthcare Sector

What are Value Stocks?

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Below is a list of notable value stocks in the healthcare sector:

  1. Global Cord Blood (NYSE:CO) - P/E: 4.29
  2. ITeos Therapeutics (NASDAQ:ITOS) - P/E: 3.27
  3. Regenxbio (NASDAQ:RGNX) - P/E: 8.98
  4. Walgreens Boots Alliance (NASDAQ:WBA) - P/E: 6.37
  5. Novartis (NYSE:NVS) - P/E: 8.01

Global Cord Blood saw an increase in earnings per share from 0.16 in Q2 to $0.17 now. Most recently, ITeos Therapeutics reported earnings per share at $1.82, whereas in Q4 earnings per share sat at $4.88. Most recently, Regenxbio reported earnings per share at $-1.58, whereas in Q4 earnings per share sat at $6.67. Walgreens Boots Alliance saw a decrease in earnings per share from 1.68 in Q1 to $1.59 now. The company's most recent dividend yield sits at 4.32%, which has increased by 0.48% from 3.84% last quarter.

This quarter, Novartis experienced an increase in earnings per share, which was $1.4 in Q4 and is now $1.46. Most recently, the company reported a dividend yield of 2.54%, which has increased by 0.3% from last quarter's yield of 2.24%.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.